Stock Chart

Citius Pharmaceuticals, Inc.(CTXR)

NASDAQ

$0.9

0.009(1.01%)

CTXR Company Profile

11 Commerce Drive

Cranford, NJ 07016
1.908.967.6677
http://www.citiuspharma.com
Sector: Health Technology
Industry: Pharmaceuticals: Major
Full Time Employees: 9

Citius Pharmaceuticals, Inc. engages in the development and commercialization of therapeutic products. It offers Mino-Lok, a patented solution to treat and salvage infected central venous catheters in patients with catheter related bloodstream infections and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for treatment of hemorrhoids. The company was founded by Ralph Montrone on January 23, 2007 and is headquartered in Cranford, NJ.

Previous Close

0.891
Open

0.8925
Bid

0
Ask

0
Day's Range

0.892 - 0.98
52 week Range

0.4 - 1.5
Volume

5194426
Avg. Volume

1855350

Market Cap

40668210
Beta (5Y Monthly)

0.8925
PE Ratio (TTM)

-1.41
EPS (TTM)

0
Earnings Date

0.8925
Forward Dividend & Yield

0.8925
Ex-Dividend Date

5235495
1y Target Est

0.8925

KEEP ME INFORMED ON CTXR UPDATES

CTXR Performance

5 Day

2.4138%
1 Month

-2.0879%
3 Month

32.9851%
YTD

-10.0908%
1 Year

-23.1897%

CTXR on Twitter

marketexclusive

Tue, Jun 2, 6:41 pm

$CTXR Citius Pharmaceuticals, Inc. (OTCMKTS:CTXR) Files An 8-K Other Events https://t.co/ZssUIzSOk6
MAISA

Tue, Jun 2, 5:12 pm

$CTXR announced in early February 2020 that this pivotal trial had reached the halfway point for enrollment. The… https://t.co/2xTbtYlGsU
yuzhu

Tue, Jun 2, 4:55 pm

RT @crusadernz: Biotech updates 06/02/20: $ADRO reverse merger -24% $EVFM offering -11% AH $BMY Ph3 UC endpoint met $YMAB PDUFA Nov 30 $NV…
BioPharmCatalyst

Tue, Jun 2, 4:50 pm

Biotech updates 06/02/20: $ADRO reverse merger -24% $EVFM offering -11% AH $BMY Ph3 UC endpoint met $YMAB PDUFA No… https://t.co/gA9me3NMf7
Fintel.io

Tue, Jun 2, 4:39 pm

$CTXR / Citius Pharmaceuticals files form 8-K - Financial Statements and Exhibits, Other Events - FORM 8-K https://t.co/cmrwQ9SwGO
IPHawk

Tue, Jun 2, 12:33 pm

$CTXR paid promote email $15,000 through venado media llc. Received 4 emails so far. I have no position.
OTC Dynamics, Inc.

Tue, Jun 2, 11:53 am

$CTXR “Broad Street Alerts” Citius Pharmaceuticals Inc. Newsletter 9:50:17 AM June 2, 2020 https://t.co/lVaJWpK9qM
David

Tue, Jun 2, 10:52 am

$TTOO and $CTXR = pure goldmines 👏🏼 and it‘s just the beginning of a great future 🙌🏼🌏
rob_tradez 💸

Tue, Jun 2, 10:51 am

$CTXR wiped out the big ask.. that should tell u something 💸💸💸
Trash Trader

Tue, Jun 2, 10:22 am

$CTXR keep going!
Sarah Katilyn

Tue, Jun 2, 10:17 am

$CTXR Citius Pharm, scanned her the other week as a swing, up 7% today. Double bottom, coming out of oversold. Head… https://t.co/zdmdJ2hpNq
Pobphorn R

Tue, Jun 2, 10:11 am

RT @rob_tradez: $CTXR looks undervalued.. would be huge on approval. just needs to get over $1 https://t.co/DqIVpt3cn0
Private Suite Network | John Cutler

Tue, Jun 2, 10:11 am

RT @CitiusPharma: Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy. Read t…
rob_tradez 💸

Tue, Jun 2, 10:07 am

$CTXR being found.. potential buyout rumors next month at 2.50/4
freddy leon

Tue, Jun 2, 10:00 am

$CTXR ladies and gentlemen, we’re gonna have to play sales people here, let’s spread the word. 🤷🏻‍♂️

CTXR on iHub

shurtha2000

Thu, May 14, 11:46 am

86 nice entry point for Covid stem cell play
ClayTrader

Tue, Apr 28, 5:39 pm

* * $CTXR Video Chart 04-28-2020 * *
europtiger

Tue, Apr 28, 1:41 pm

Got 1,10
GM26

Tue, Apr 28, 12:27 pm

Citius Pharmaceuticals, Inc. (OTCMKTS:$CTXR) Files An 8-K Other
MADDSTACKER

Tue, Apr 28, 10:36 am

Bring on the covid news ! 🙂
Diana15

Thu, Apr 23, 11:46 am

Some buying interest building last 2 days.
reverse_long

Sat, Apr 11, 12:14 am

One of the scummiest stocks on the NASDAQ
jonnyvs

Thu, Apr 2, 9:43 am

Nice start here! Lookin for that 1.00 break!
Diana15

Thu, Apr 2, 6:34 am

Can you post the source (link) for this.
US_BLUES

Wed, Apr 1, 10:33 pm

Long #$CTXR
Diana15

Wed, Apr 1, 4:40 pm

Well the last free published short amount was
ClayTrader

Wed, Apr 1, 4:05 pm

* * $CTXR Video Chart 04-01-2020 * *
Seann

Wed, Apr 1, 3:43 pm

And I wasn’t intending to mean this was
Diana15

Wed, Apr 1, 3:41 pm

Going off topic. The bottom line it is
Seann

Wed, Apr 1, 3:40 pm

So you are saying all the CV stocks
jonnyvs

Wed, Apr 1, 3:38 pm

Short covering or true breakout here?
Diana15

Wed, Apr 1, 3:38 pm

That's a special situation. It was an offering.Well
Seann

Wed, Apr 1, 3:32 pm

$AYTU on March 9th before offerings were announced.
Diana15

Wed, Apr 1, 3:27 pm

Name one real company that has had that.
Seann

Wed, Apr 1, 3:26 pm

Some stocks have traded their O/S more than
Diana15

Wed, Apr 1, 3:24 pm

Come on. At 10x that would be 166%
Seann

Wed, Apr 1, 3:22 pm

Comparative with other stocks related to CV.
Diana15

Wed, Apr 1, 3:21 pm

Low volume? It is 10x the average volume
Seann

Wed, Apr 1, 3:17 pm

Nice movement today to recover from PM.
starkd748

Wed, Apr 1, 12:03 pm

Gotta stay above .80s
jonnyvs

Wed, Apr 1, 11:35 am

Here we go
Diana15

Wed, Apr 1, 11:19 am

Looks like it may be starting to ramp
Seann

Wed, Apr 1, 11:18 am

NHOD
Actualfactual

Wed, Apr 1, 11:15 am

If she can break 80 I think she
Seann

Wed, Apr 1, 11:10 am

Only if volume comes in to outpace the
jonnyvs

Wed, Apr 1, 11:05 am

Still say this one breaks out today
jonnyvs

Wed, Apr 1, 8:37 am

Low float for a penny play too. This
Diana15

Wed, Apr 1, 8:23 am

???. All i know is Pre market reaction
[SMART MONEY]

Wed, Apr 1, 8:19 am

.80 dip from 1.10
Diana15

Wed, Apr 1, 8:10 am

Good news.
Diana15

Wed, Mar 11, 10:17 am

No kidding!!!! All small and also emgining bio
reverse_long

Wed, Mar 11, 10:15 am

The email was a compensated promotional email. $CTXR
Diana15

Wed, Mar 11, 10:13 am

Don't really care. Just posting an informative e
reverse_long

Wed, Mar 11, 10:12 am

This is not true. They had a DISCUSSION
Diana15

Wed, Mar 11, 9:35 am

Biotech Nearing the End of Phase 3 Trial
Diana15

Wed, Mar 4, 12:18 pm

Took a position in $CTXR this morning. I
vhgier

Wed, Mar 4, 10:56 am

investor gig soon....should be interesting.
Roland Rick Perry

Tue, Feb 25, 1:43 pm

4 Million Catheter-Related Blood Infections Yearly.
reverse_long

Mon, Feb 17, 12:30 am

$CTXR recent SEC financials look garbage. Lots of
reverse_long

Mon, Feb 10, 3:12 am

$CTXR looking weak. Most likely a follow up
KJAX

Fri, Feb 7, 1:24 pm

Why would they dump? June is the
reverse_long

Fri, Feb 7, 6:10 am

Nice to see the pump is still going
conix

Wed, Feb 5, 10:46 am

We are continuing our coverage of Citius Pharmaceuticals,
Roland Rick Perry

Tue, Feb 4, 12:39 pm

Price Target Upped to $4.00
Roland Rick Perry

Wed, Jan 29, 4:54 pm

New Corporate Deck.

Stock Chart

Stock Chart

Citius Pharmaceuticals, Inc.(CTXR)

$0.9

CTXR Company Profile

KEEP ME INFORMED ON CTXR UPDATES

CTXR Performance

CTXR on Twitter

CTXR on iHub

CTXR News

Citius Receives Positive FDA Feedback on Its Submitted Plan to Study Catheter Compatibility for Mino-Lok® Therapy

Citius Announces Expanded Access Program for Investigational Phase 3 Mino-Lok®

Citius Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Should You Be Concerned About Citius Pharmaceuticals, Inc.'s (NASDAQ:CTXR) Historical Volatility?

Citius Announces $7.5 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

Citius Announces Data on NoveCite Mesenchymal Stem Cells (NC-MSCs) to be Presented at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

Citius Pharmaceuticals Issues May 2020 Shareholder Letter

Citius Announces Pre-IND Submission to FDA Under the Coronavirus Treatment Acceleration Program for a Novel Stem Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) in COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Pharmaceuticals Announces Publication in Antimicrobial Agents and Chemotherapy Journal of Positive Preclinical Results for Mino-Lok® in Rapidly Eradicating Candida Auris

Citius Pharmaceuticals to Deliver Virtual Presentation at the Spring Investor Summit

Here's Why We Worry About Citius Pharmaceuticals's (NASDAQ:CTXR) Cash Burn Situation

Citius Pharmaceuticals, Inc. to Present at the Spring Investor Summit on March 25th-26th in New York City

Citius Pharmaceuticals to Present at the 2020 LD Micro Virtual Conference

Citius Pharmaceuticals Cites Independent Estimates of Total Available World Market for Mino-Lok®

Citius Pharmaceuticals to Present at Noble Capital Markets' 16th Annual Investor Conference

Citius Achieves 50% Patient Enrollment in Phase 3 Mino-Lok® Pivotal Trial

Citius Pharmaceuticals Regains Compliance with Nasdaq Listing Requirements

Biotech Companies Think Big with Specialization - Fighting Deadly Bacteria and Viruses

Citius Announces Positive Outcome of Interim Futility Analysis for its Phase 3 Mino-Lok® Pivotal Trial